ARQT Arcutis Biotherapeutics, Inc.

NASDAQ
$27.61

Arcutis Biotherapeutics, Inc. (ARQT) Earnings News

Earnings press releases, previews and reviews for Arcutis Biotherapeutics, Inc. (ARQT), newest first. Our most recent is review: Arcutis Misses Badly on Earnings as a Spending Surge Overshadows a ZORYVE Revenue Beat and Higher Guidance.